Liechtenstein Pharmaceutical and Medical Goods Expenditure Share (2024)
Liechtenstein's Pharmaceutical and Medical Goods Expenditure Share: 12.2 % of current health expenditure in 2024, unchanged YoY.
Liechtenstein (2024)
12.2
% of current health expenditure
unchanged YoY
YoY Change
unchanged
percentage points
Trend
neutral
Series length
12
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2024 | 12.2 | unchanged |
| 2023 | 12.2 | +0.5pp |
| 2022 | 11.7 | +0.3pp |
| 2021 | 11.4 | -0.2pp |
| 2020 | 11.6 | +0.5pp |
| 2019 | 11.1 | -1.1pp |
| 2018 | 12.2 | +0.1pp |
| 2017 | 12.1 | -0.1pp |
| 2016 | 12.2 | unchanged |
| 2015 | 12.2 | +0.3pp |
| 2014 | 11.9 | +0.1pp |
| 2013 | 11.8 | n/a |
About this Dataset
Liechtenstein recorded 12.2 % of current health expenditure in 2024. That is unchanged on the previous period. Across 2013–2024 the series ranges from 11.1 % of current health expenditure in 2019 to 12.2 % of current health expenditure in 2016.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Liechtenstein.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Liechtenstein. It is published by Eurostat and updated annually.
The most recent observation covers 2024. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2013–2024 (12 observations).
The series peaked at 12.2 % of current health expenditure in 2016 and reached its lowest recorded value of 11.1 % of current health expenditure in 2019. The latest reading is 12.2 % of current health expenditure in 2024. That is unchanged on the previous period.